Log in to save to my catalogue

Inhibitory mechanism of reveromycin A at the tRNA binding site of a class I synthetase

Inhibitory mechanism of reveromycin A at the tRNA binding site of a class I synthetase

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_aa106fd7577240a4b8e1ff9e7d96b4fa

Inhibitory mechanism of reveromycin A at the tRNA binding site of a class I synthetase

About this item

Full title

Inhibitory mechanism of reveromycin A at the tRNA binding site of a class I synthetase

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-03, Vol.12 (1), p.1616-1616, Article 1616

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The polyketide natural product reveromycin A (RM-A) exhibits antifungal, anticancer, anti-bone metastasis, anti-periodontitis and anti-osteoporosis activities by selectively inhibiting eukaryotic cytoplasmic isoleucyl-tRNA synthetase (IleRS). Herein, a co-crystal structure suggests that the RM-A molecule occupies the substrate tRNA
Ile
bindin...

Alternative Titles

Full title

Inhibitory mechanism of reveromycin A at the tRNA binding site of a class I synthetase

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_aa106fd7577240a4b8e1ff9e7d96b4fa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_aa106fd7577240a4b8e1ff9e7d96b4fa

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-21902-0

How to access this item